Étude des voies d’apprêtement des antigènes viraux menant à la présentation antigénique par les CMH de classe I
Immune control of viral infections is mainly carried out by cytotoxic CD8+ T lymphocytes. To achieve this, CD8+ T lymphocytes must be able to recognize infected cells and eliminate them. This recognition of infected cells occurs by the interaction of the T cell receptor (TCR) of CD8+ T lymphocytes and viral peptides associated with major histocompatibility complex (MHC) class I on the surface of host cells. This interaction is the key element triggering the elimination of infected cells. This emphasizes the major role of cellular mechanisms leading to the generation of antigenic peptides from viral proteins.  The traditional view of antigen presentation by MHC molecules proposes two segregated pathways. Indeed, it is widely accepted that endogenous antigens are processed by the ''classical'' MHC class I presentation pathway. This pathway involves the degradation of intracellular antigens by the proteasome complex in the cytoplasm of the cell, the resulting peptides are then translocated in the endoplasmic reticulum where they are loaded on MHC class I molecules, and finally peptide-MHC complex are exported at the cell surface to activate CD8+ T lymphocytes. In contrast, exogenous antigens internalized by endocytosis or phagocytosis are processed by hydrolases in the lytic endovacuolar compartment and the resulting peptides are loaded on MHC class II molecules. Thereafter, vesicle recycling mechanisms transport the peptide-MHC class II complex on the cell surface where they can stimulate CD4+ T lymphocytes.  However, the strict segregation of these two pathways has been revisited to account for the ability of antigen presenting cells to present exogenous antigens on MHC class I molecules by a process called cross-presentation. Moreover, the recent finding that intracellular peptides might also be presented by MHC class II molecules clearly emphasized the presence of interactions between these two antigen processing pathways that transgress the previously established dogma. The objective of the work presented here was to characterize the antigen processing pathways leading to antigen MHC class I presentation during herpes simplex type I (HSV-1) infection. In the results reported here, we describe a new antigen processing pathway resulting from the formation of autophagosomes in HSV-1 infected cells. This new pathway allows the transfer of viral antigens in a lytic vacuolar compartment during the late phase of infection. The development and activation of this second pathway of antigen processing leads to an increased MHC class I presentation of the viral glycoprotein B (gB) used as a model in this study. Moreover, our results describe the establishment of a new form of autophagosomes derived from the nuclear envelope in response to HSV-1 infection. This new form of autophagosomes also contributes to viral antigen transfer to lytic vacuolar compartment in parallel to the action of classical autophagy. Our results also show a close collaboration between the classical MHC class I presentation pathway and vacuolar pathway induced by the formation of autophagosomes, still reinforcing the idea that these two pathways interact together to ensure optimal antigens processing during viral infection. In the second part of the work presented here, we use HSV-1 infection and the resulting viral glycoprotein B to study membrane trafficking allowing the transfer of gB to degradative vacuolar compartments. Our results highlight the role of the endoplasmic reticulum in antigen transfer mechanisms that induce an amplified MHC class I presentation of the viral glycoprotein B.
phagosomes lymphocyte T CD8+ macrophage autophagy antigen presentation herpes CD8+ T lymphocyte MHC antigen processing macrophage endoplasmic reticulum phagosome